tiprankstipranks
Trending News
More News >
Icu Medical (ICUI)
NASDAQ:ICUI
US Market
Advertisement

ICU Medical (ICUI) Earnings Dates, Call Summary & Reports

Compare
206 Followers

Earnings Data

Report Date
Mar 04, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.67
Last Year’s EPS
2.11
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for ICU Medical with significant revenue growth, improved earnings, and increased guidance. However, challenges such as tariff impacts and segment declines create some headwinds. Overall, the highlights outweigh the lowlights, leading to a predominantly positive sentiment.
Company Guidance
In the third quarter of 2025, ICU Medical reported a total revenue of $533 million, reflecting a 5% growth on an organic basis, despite an 8% year-over-year decline when reported. The company's gross margins improved, and operating expenses decreased, resulting in increased EBITDA and EPS. Specifically, adjusted EBITDA was $106 million, and EPS reached $2.03. The Consumables business saw an 8% reported growth, while the IV Systems business grew by 9% reported and 8% organic. The company has repaid $273 million in principal year-to-date, and free cash flow generation improved. For the full year, ICU Medical adjusted its EBITDA guidance upward to a range of $395 million to $405 million and revised its EPS guidance to $7.35 to $7.65 per share. The company expects tariffs to impact the fourth quarter, with expenses estimated between $12 million and $14 million. Meanwhile, operating expenses for Q4 are anticipated to be around 25.5% of revenue, slightly higher than Q3 but below prior guidance.
Revenue and Earnings Growth
ICU Medical reported Q3 revenue of $533 million, a 5% organic growth year-over-year. Gross margins increased, operating expenses declined, leading to more EBITDA and EPS. Adjusted EBITDA was $106 million, and EPS was $2.03.
Consumables and IV Systems Performance
Consumables business grew 8% reported and 7% organic, reaching record sales levels. IV Systems business grew 9% reported and 8% organic, driven by new installations and strong demand.
Free Cash Flow and Debt Repayment
Free cash flow generation improved with $273 million in principal debt repaid year-to-date. The company also completed refinancing to save approximately $2 million annually in interest expense.
Increased Full Year Guidance
Full year EBITDA guidance increased to a range of $395 million to $405 million, and adjusted EPS guidance updated to $7.35 to $7.65 per share.
Product Innovation and FDA Interactions
The company is actively engaged with the FDA for new product approvals and has ongoing innovations in infusion systems and software solutions.

ICU Medical (ICUI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ICUI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 04, 2026
2025 (Q4)
1.67 / -
2.11
Nov 06, 2025
2025 (Q3)
1.43 / 2.03
1.5927.67% (+0.44)
Aug 07, 2025
2025 (Q2)
1.50 / 2.10
1.5634.62% (+0.54)
May 08, 2025
2025 (Q1)
1.28 / 1.72
0.9679.17% (+0.76)
Feb 27, 2025
2024 (Q4)
1.48 / 2.11
1.5734.39% (+0.54)
Nov 12, 2024
2024 (Q3)
1.25 / 1.59
1.571.27% (+0.02)
Aug 07, 2024
2024 (Q2)
1.00 / 1.56
1.88-17.02% (-0.32)
May 07, 2024
2024 (Q1)
0.82 / 0.96
1.74-44.83% (-0.78)
Feb 27, 2024
2023 (Q4)
1.19 / 1.57
1.6-1.88% (-0.03)
Nov 06, 2023
2023 (Q3)
1.39 / 1.57
1.75-10.29% (-0.18)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ICUI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$129.67
Aug 07, 2025
$129.91$112.85-13.13%
May 08, 2025
$142.87$138.30-3.20%
Feb 27, 2025
$149.75$146.33-2.28%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Icu Medical (ICUI) report earnings?
Icu Medical (ICUI) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
    What is Icu Medical (ICUI) earnings time?
    Icu Medical (ICUI) earnings time is at Mar 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ICUI EPS forecast?
          ICUI EPS forecast for the fiscal quarter 2025 (Q4) is 1.67.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis